Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ELOC-mutant renal cell carcinoma: practical diagnostic features and differential considerations.

Journal of clinical pathology - 19 Mar 2026

Lin Meifang, Chen Chuncheng, Guo Shujing, Wu Yue, Lin Fenglian, Ding Xin

Abstract excerpt

AIMS: ELOC (TCEB1)-mutant renal cell carcinoma (RCC) is a recently recognised entity in the 2022 WHO classification. Due to overlapping features, it is frequently misdiagnosed as clear cell RCC (CCRCC). This study characterises the clinicopathological, immunohistochemical and molecular features of six ELOC-mutant RCCs to aid in their diagnostic distinction. METHODS: Twenty-eight RCCs initially diagnosed as CCRCC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Biomarkers, Tumor
Share to Carcinoma, Renal Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diagnosis, Differential

Share to DNA Mutational Analysis

Share to Immunohistochemistry

Share to Kidney Neoplasms

Share to Transcription Factors

Source

Identifiers

PMID: 41167807
DOI: 10.1136/jcp-2025-210059

Genes

ELOC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ELOC-mutant renal cell carcinoma: practical diagnostic features and differential considerations.PMID 41167807Read ↗

ELOC-mutated Renal Cell Carcinoma: Clinicopathologic, Immunohistochemical, and Molecular Genetic Analysis of 35 Cases.Semantic proximity Read ↗

ELOC-Mutated Renal Cell Carcinoma is a Rare Indolent Tumor With Distinctive Genomic Characteristics.Semantic proximity Read ↗

[Clinicopathological and molecular genetic characteristics of ELOC mutated renal cell carcinoma].Semantic proximity Read ↗

Comprehensive Analysis of 15 Cases of ELOC-RCC and Identification of Novel Mutation SiteSemantic proximity Read ↗

TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype.Semantic proximity Read ↗

Renal tumors harboring FLCN mutations: Case series from clinical practice.Semantic proximity Read ↗

The New WHO Category of “Molecularly Defined Renal Carcinomas”: Clinical and Diagnostic Features and Management ImplicationsSemantic proximity Read ↗

Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical CourseSemantic proximity Read ↗

[ELOC-mutated renal cell carcinoma with new mutation site combined with lung adenocarcinoma: report of a case].Semantic proximity Read ↗

Subtyping atypical eosinophilic renal cell tumours through integrated morphological, immunohistochemical, and mutational characters.Semantic proximity Read ↗

Acquired Cystic Kidney Disease-associated Renal Cell Carcinoma (ACKD-RCC) Harbor Recurrent Mutations in KMT2C and TSC2 Genes.Semantic proximity Read ↗

Chromophobe renal cell carcinoma: Novel molecular insights and clinicopathologic updatesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.